Publication | Open Access

Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial

MedicineVersus Conventional TherapyClinical TrialsCancer GenomicsImmune Checkpoint InhibitorBiostatisticsShiva TrialCancer TreatmentOncologyRadiation OncologyCancer ResearchRefractory CancerMolecular OncologyHealth Sciences